Trials / Completed
CompletedNCT07058051
Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 12 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.
Detailed description
Cross-Sectional
Conditions
Timeline
- Start date
- 2025-07-17
- Primary completion
- 2025-11-13
- Completion
- 2025-11-13
- First posted
- 2025-07-10
- Last updated
- 2025-11-19
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07058051. Inclusion in this directory is not an endorsement.